Celltrion Files Stelara Biosimilar In US And Canada

Korean Firm Submits CT-P43 Ustekinumab Candidate To US FDA And Health Canada

 
• By David Wallace
  
US and Canadian flags
Celltrion has submitted its ustekinumab biosimilar in North America • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products